ICOS and allergic asthma: The finding that the MAPKs inhibitors very effectively inhibited several cytokines in CD4+ T cells costimulated through CD28 and ICOS, prompted us to investigate whether these selective MAPKs inhibitors may be active in an animal model of allergic asthma.